IN Brief:
- NFX UK has secured $650,000 from Coefficient Giving to expand its novel foods support network.
- The network has engaged more than 260 organisations and individuals across 14 countries since launch.
- Regulatory readiness is becoming a decisive factor for precision fermentation, cultivated foods, and other novel food technologies.
Reading Scientific Services Ltd is scaling its Novel Foods Expert Network UK after NFX UK secured $650,000 in funding from Coefficient Giving.
The funding will allow NFX UK to deepen its work in the UK and expand into Europe for the first time. The network supports companies developing novel foods, including cell-cultivated products and precision fermentation ingredients, by helping them navigate regulatory complexity and improve approval readiness.
NFX UK was launched in September 2025 as the UK’s first dedicated Novel Foods Expert Network. Since then, it has engaged stakeholders across 14 countries, built a community of more than 260 organisations and individuals, supported more than 15 structured regulator engagement activities, and developed dialogue with the Food Standards Agency and Food Standards Scotland.
The network is organised around three pillars: ecosystem building, regulatory engagement, and knowledge exchange. That structure reflects the bottleneck facing many novel food companies. Scientific capability may be advancing quickly, but regulatory approval depends on evidence packages, safety data, manufacturing information, exposure assessment, analytical characterisation, and clear communication with authorities.
Regulatory uncertainty remains one of the biggest barriers to commercialisation. Novel foods can attract investment, technical talent, and customer interest, but they cannot enter the market without robust approval pathways. A promising ingredient or product can lose momentum if the dossier is weak, incomplete, or poorly aligned with regulatory expectations.
RSSL brings analytical and contract research capability into that environment. Novel food applications often require data on composition, contaminants, toxicology, allergenicity, nutritional impact, production process, stability, and intended use. Precision fermentation, cultivated products, and other emerging technologies also require close attention to strain characterisation, residual materials, process controls, purification, and batch consistency.
The move into Europe comes as the region debates how to support alternative proteins while maintaining high food safety standards. Europe has strong scientific institutions and food manufacturing capability, but companies often face lengthy and demanding approval processes. Support networks can help innovators understand what evidence is required before they commit to expensive submissions.
The European Commission’s protein resilience plan has already tied domestic protein production, livestock strategy, processing capacity, and import dependency into a wider industrial policy discussion. NFX UK’s expansion sits in the same landscape because novel foods and alternative proteins are increasingly being treated as questions of resilience, sustainability, and manufacturing capability.
The UK has been trying to position itself as a more responsive environment for food innovation. Engineering biology, precision fermentation, and cultivated food technologies have all been identified as areas with economic and strategic potential. Regulatory excellence is part of that proposition. Research and manufacturing capacity will not create market advantage if approvals are slow, uncertain, or poorly understood.
That does not mean weaker regulation. Novel food approval exists to protect consumers and maintain confidence. The opportunity lies in making the process clearer, more evidence led, and more predictable. Companies need to know what data to generate, regulators need high quality submissions, and investors need a realistic view of timelines and risk.
The expansion of NFX UK could help bridge the gap between laboratory success and production reality. Novel food dossiers must describe both the product and the process in sufficient detail. Manufacturing scale up, quality systems, contamination controls, traceability, and batch reproducibility are not peripheral details; they are part of the regulatory case.
There is also a supply base to build. Precision fermentation and cultivated food production depend on feedstocks, bioreactors, media, downstream processing, analytical labs, sterile operations, packaging, cold chain, and specialist skills. Regulatory readiness has to connect with industrial readiness, because a product that is safe in principle still needs a controlled manufacturing system behind it.
Jacinta George, Managing Director and VP at RSSL, said: “Our ambition is to make the UK the world’s leading environment for responsible novel food innovation, and we are helping to build the infrastructure needed to make that happen. At RSSL, we bring together regulatory science expertise, analytical capability and ecosystem leadership, with NFX UK serving as the platform through which this expertise delivers national and now international impact.”
The $650,000 funding gives NFX UK a stronger platform to coordinate that work across the UK and Europe. Novel foods will not advance on enthusiasm alone. The sector needs evidence, process control, and regulatory confidence, and the approval pathway is now part of the industrial infrastructure for future food manufacturing.
